DOTHAN, Ala. (WTVY) - Alabama carried out another execution when it put death row inmate Demetrius Frazier to death on Thursday night, but it’s not the death some have waited on for decades.

ATLANTA, Ga. (Atlanta News First) - About a year after he was arrested at the 2024 Grammy Awards ceremony in Los Angeles, Atlanta hip-hop legend Killer Mike has filed a lawsuit against the venue’s ...

The Deal of the Week is Atlus' RPG game 'Metaphor ReFantazio' discounted by 30% to $48.99. In total, various games across different genres are discounted, with notable titles being mentioned for their ...

The Instinct sits in Garmin’s line-up as a rugged, adventure-ready running watch. Its durable design, excellent battery life and extensive range of features have made it a popular option among ...

"If people like Easter eggs, this show is going to be an Easter egg hunt," said showrunner Clyde Phillips. By Josh Wigler Contributor Spoilers ahead through season one, episode eight (“And in ...

Natural killer (NK) cells are the predominant innate lymphocyte subsets that mediate anti-tumor and anti-viral responses, and therefore possess promising clinical utilization. NK cells do not express ...

Over time, that name morphed into "killer whales." Scientists don't know whether orcas kill for fun. The marine mammals do some things, like killing and tossing dead porpoises in the air ...

Visa is the first partner for X Money accounts, which X says will support instant bank transfers and P2P payments. Visa is the first partner for X Money accounts, which X says will support ...

Elon Musk-owned social network X announced a partnership with Visa to handle person-to-person payments for its upcoming X Money product. The company will use Visa Direct, which is Visa’s ...

A defendant dubbed by police as the "shopping cart killer" is on trial in Virginia accused of slaying two women in 2021, having met them on social media dating apps and taking them to his hotel room.

Atalanta Therapeutics has bagged $97 million, money the biotech plans to use to launch clinical trials for its small interfering RNA (siRNA) candidates in epilepsy and Huntington’s disease.